Navigation Links
Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Date:9/4/2007

WATERBURY, Conn., Sept. 4 /PRNewswire/ -- Therap Services, the leading provider of on-line applications focused on the developmental disability community, has appointed Maureen Noonan and Kara Blevins as Customer Support Specialists. The two experienced developmental disability industry clinicians will provide support and training to Therap users.

"We are excited to have both Maureen and Kara in our team. They bring with them their wealth of knowledge and experience to continue improving the quality of support that we provide to our customers," said Justin Brockie, Director of Customer Support and Training.

Maureen received her degree in Bachelor of Fine Arts from the University of Connecticut. Maureen has over 10 years of experience in the developmental disability community. Maureen was an Employment Specialist at SARAH, Inc., a Residential Care Manager for Homestead Residential Services and a Residential Director at PrimeCare, where she supervised a 24-hour community living arrangements for individuals with developmental disabilities. Maureen has been using Therap applications for the past four years in her role as Residential Director prior to joining Therap.

"It is an exciting prospect to continue working with the developmental disabilities community and I look forward to being part of a global company where technology is imparted to improve the quality of care worldwide," said Maureen.

Kara received her Bachelor's degree in Psychology and Philosophy from the University of Hartford. After graduation Kara worked as a Classroom Coordinator at Benhaven School. Kara then worked as a Residential Director at PrimeCare, managing the support and care for individuals with developmental disabilities, where she gained experience in using Therap applications.

Kara stated, "Joining Therap has given me the opportunity to not only use my current skills in helping others, but also to learn so much more about the developmental disability indu
'/>"/>

SOURCE Therap Services
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
3. Consensus on "Combination Therapy" for Breast Cancer
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Gene Therapy shows promise in treating Hemophilia
8. "Make AIDS Therapy affordable" - Physicians demand
9. Acupuncture superseeds massage therapy for short term relief of pain
10. Hormone replacement Therapy a headache
11. Simple Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... The award-winning docume...ision debut on the Sundance Channel on World Diabe... Directed by Academy Award® nominee Edward La...ith type 1 diabetes amid the verdant mountains and...t countries. The children are supported with life-...
(Date:11/9/2009)...9 Speaker Nancy Pelosi...ons in the Affordable Health Care for America ...id and reduce Medicare Part D costs for people liv...aturday by a vote of 220 to 215: ,, "Effective...lity of life for thousands of Americans living wit...
(Date:11/9/2009)...rt Experimental Procedure for Preteen Son - ,...For parents of children with cancer, the hopeful n... improved for decades. Among the bad news -- treat.... ,, Boys diagnosed with cancer who have reac...rve their fertility: before undergoing cancer trea...
(Date:11/9/2009)...l use funds to move lab findings into human therap...ain from nerve damage ,, ANN ARBOR, Mich., Nov... University of Michigan Department of Neurology ha...l therapy for neuropathic pain, a difficult-to-tre...ause of damage to nerve without obvious tissue inj...
(Date:11/9/2009)...r 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), th...y announced the availability of INTUNIV (guanfacin...he United States for the treatment of Attention-De...d adolescents ages 6 to 17. INTUNIV, a once-daily...nonscheduled alpha-2A receptor agonist approved fo...
Breaking Medicine News(10 mins):Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...mail intervention program is an effective way to s... helping people move more, sit less, and make heal...te Division of Research study in the American Jou...g 787 Kaiser Permanente Northern California employ...
...cancer bringing total raised by LIFE to $5.6 milli...ros including World Golf Hall of Fame members Beth... Stanford, Morgan Pressel, Brittany Lincicome, Hel...ast Cancer) Event hosted by LPGA veteran Val Skinn...
...ewswire-Asia-FirstCall/ -- BMP Sunstone,Corporatio...y"), today announced,financial results for the fir...Highlights from the First Quarter Ended March 31, ....7 million from $7.7 million in the prior, y...
...es, Inc. (Nasdaq: GTIV ), a leading provider of ... that on May 14, 2009 it received official notific...ce with the exchange,s independent director requir...ows: , , , until the earlier of the Com...
...ls, Inc. (Nasdaq: TRBN ) announced today that da...dy (15002) of TRU-015 for rheumatoid arthritis wil...gue Against Rheumatism (EULAR) annual meeting in C...TRUBIONLOGO ) , , Data from the first course of r...
...y Corporation, (Nasdaq: QG L Y), www.quigley...any,s possible alternative strategies going forwar...rding the unexpected positive finding for its QR-3...al are awaited, the Company,s Board of Directors a...
Other Medicine News:Health News:Workplace e-mail intervention program helps people sit less and eat better 2Health News:Workplace e-mail intervention program helps people sit less and eat better 3Health News:LIFE 10th Anniversary Event Delivers Big Names and Big Dollars for Breast Cancer Fight 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 3Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 4Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 5Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 6Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 7Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 8Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 9Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 10Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 11Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 2Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 2Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 4Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 2Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 3Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 4
(Date:11/9/2009)...INCETON JUNCTION, N.J., Nov. 9 Unw...edical devices, but recognizing today,s economic c...h quality aesthetic laser systems, introduces the ...priced at under $50,000. ,, The MOSAIC CO2 off...tional technology including scanning and stamping ...
(Date:11/9/2009)...N ARBOR, Mich., Nov. 9 Thomson R...cal Xpert(TM) CareFocus, a leading clinical survei... at-risk patients in real-time and respond immedia...cost of treatment. ,, This upgrade is available...ost. ,, CareFocus 2.0 contains several powerf...
(Date:11/9/2009)...NNYVALE, Calif., Nov. 9 ...eutical company focused on developing and commerci...eatment of immune mediated diseases and cancer, to..., Preclinical Development will provide an overview...man Curhan Ford,s 6th Annual Investor Summit. ,...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 1Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 2Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 1CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 4Alzheimers lesions found in the retina 59918 1Alzheimers lesions found in the retina 59918 2
...30 Peptimmune, Inc. a privately,held biotechnolog...Number,7,381,790 (the ,790 patent) which protects ...copolymer for the treatment of autoimmune diseases...cending dose,double-blind, placebo-controlled rand...Following establishment of safety at potentially t...
... 30 Wound Care Innovations, LLC,a subsidiary of W...Board:,WNDM), announced today an evidence based st...ical performance of their advanced wound care coll...lcers. "According to data,released by the Centers ...ffects nearly 24 million people in the United Stat...
Other Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2
...nitoring System™ expands hospital-grade moni...ields of subacute care and disease state managemen...ss a full range of clinical applications, from con...e hospital, to periodic monitoring of patients out...
...ess capability to Welch Allyn's comprehensive hard...onitoring concept to provide vital signs data and ...xNet links multiple devices such as ambulatory wir...monitors to Acuity® Central Monitoring Station...
Wireless Propaq® CS
Vital Signs Monitor
Medicine Products: